Monique Lariviere
Nurse Practitioner · Hyannis, MANPI 1407447378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 275 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,853 and has fallen 97.4% since, to $74 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$806
- GSK$719
- Boehringer Ingelheim$588
- Grifols USA, LLC$472
- Regeneron Healthcare Solutions, Inc.$443
- Mylan Specialty L.p.$331
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,47299%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $806 |
| GSK | 34 | $719 |
| Boehringer Ingelheim | 30 | $588 |
| Grifols USA, LLC | 23 | $472 |
| Regeneron Healthcare Solutions, Inc. | 20 | $443 |
| Mylan Specialty L.p. | 19 | $331 |
| Amgen | 13 | $258 |
| Philips North America LLC | 13 | $236 |
| Genentech USA, Inc. | 7 | $190 |
| Jazz Pharmaceuticals Inc. | 10 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $173 |
| Sanofi | 7 | $170 |
| Harmony Biosciences LLC | 5 | $163 |
| Paratek Pharmaceuticals, Inc. | 6 | $111 |
| Novartis | 6 | $107 |
| Electromed, Inc. | 6 | $100 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Baxter Healthcare | 4 | $80 |
| United Therapeutics Corporation | 4 | $63 |
| Biomerieux Inc | 2 | $49 |
| Inogen, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $30 |
| Gilead | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- inCourage$116
How this compares
$5,519 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $22,138 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $16,117 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $8,219 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $6,202 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $408 |
| Montelukast Sodium | 31 | $390 |
| Famotidine | 19 | $213 |
| Tramadol Hcl | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $719 | $28,34037 claims |
| AstraZenecaBreztri Aerosphere | $806 | $16,11718 claims |
| Boehringer IngelheimStiolto Respimat | $588 | $8,21914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Other nurse practitioner in Hyannis
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
- Lauren BurkeBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.